Pancreatic Cancer Research

ResearcherHarbin Medical UniversityActive in the last 2 years

Weihui Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3180-3004; OpenAlex author ID A5082869088. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. PCDH1 facilitates migration, proliferation, and stemness of pancreatic cancer cells through PI3K-Akt signaling. Co-author DOI 10.3389/fonc.2025.1696695↗
  2. Dictamnine inhibits pancreatic cancer cell growth and epithelial-mesenchymal transition by blocking the PI3K/AKT signaling pathway. Last author DOI 10.4149/neo_2022_211016n1474↗
  3. Role of vitamin D receptor gene polymorphisms in pancreatic cancer: a case-control study in China. Co-author DOI 10.1007/s13277-015-3119-6↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dali Zhao · 1 shared paper, 2025 · strength 0.30
  2. Zhiqiang Yang · 1 shared paper, 2025 · strength 0.30
  3. Ye Song · 1 shared paper, 2022 · strength 0.16
  4. Dongbo Xue · 1 shared paper, 2022 · strength 0.16
  5. Zhiqiang Zhang · 1 shared paper, 2022 · strength 0.16
  6. Lin Wei · 1 shared paper, 2015 · strength 0.06
  7. Lei Li · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.